Clinical Outcomes of EUS-GE
Author | Year | Study design | Sample size (n) | EUS-GE technique | B/M | TS/CS (%) | Rate of AEs (%) | Details of AEs | Reintervention (%) |
---|---|---|---|---|---|---|---|---|---|
Khashab et al17 | 2015 | M-R | 10 | D-GE ( |
1/9 | 90/90 | 0 | - | 0 |
Tyberg et al18 | 2016 | M-R | 26 | D-GE ( |
9/17 | 92/85 | 11.5 | Peritonitis ( |
N/A |
Itoi et al21 | 2016 | S-P | 20 | EPASS ( |
0/20 | 90/100 | 10 | Misdeployment ( |
0 |
Chen et al20 | 2017 | M-R | 30 | D-GE ( |
0/30 | 87/87 | 16.7 | Misdeployment ( |
3 |
Khashab et al22 | 2017 | M-R | 30 | EPASS ( |
0/30 | 87/87 | 16 | Misdeployment ( |
3 |
Perez-Miranda et al24 | 2017 | M-R | 25 | D-GE ( |
8/17 | 88/84 | 13.6 | Bleeding ( |
0 |
Chen et al26 | 2018 | M-R | 26 | D-GE ( |
26/0 | 96.2/84 | 11.5 | Misdeployment ( |
4.8 |
Chen et al23 | 2018 | M-R | 74 | D-GE ( |
25/49 | 94.2/92.3 | 6.8 | Misdeployment ( |
9.5 |
Ge et al25 | 2019 | S-R | 22 | D-GE ( |
0/22 | 100/96 | 18.1 | Misdeployment ( |
4.5 |
Kerdsirichairat et al27 | 2019 | M-R | 57 | D-GE ( |
23/34 | 93/90 | 3.5 | Leakage ( |
15.1 |
EUS-GE, endoscopic ultrasonography-guided gastroenterostomy; B, benign; M, malignant; TS, technical success; CS, clinical success; AEs, adverse events; S-P, single-center prospective; S-R, single-center retrospective; M-R, multicenter retrospective; D-GE, direct gastroenterostomy; BA-GE, balloon-assisted gastroenterostomy; NOTES, natural orifice transluminal endoscopic surgery; EPASS, EUS-guided double balloon-occluded gastrojejunostomy bypass; LAMS, lumen apposing metal stent; N/A, not available.